Defects of mitochondrial proteins and pediatric heart disease

Progress in Pediatric Cardiology

Volumn 6, Issue 1, 1996, Pages 83-90

  Strauss, Arnold W ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Cardiomyopathy; Carnitine; Fatty acid oxidation; Mitochondria; Mitochondrial genome; Molecular genetics; Myocardial energetics

Indexed keywords

FATTY ACID; MITOCHONDRIAL DNA; PROTEIN;

CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; ENERGY TRANSFER; FATTY ACID OXIDATION; GENETIC DISORDER; HEART FUNCTION; HEART MITOCHONDRION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEFECT; REVIEW;

EID: 0030220792     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/1058-9813(96)00174-9     Document Type: Article

References (50)

1. [1] Michels V, Mol PP, Miller FA et al. The frequency of dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992;326:77-82.
2. [2] Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med 1994;13:913-919.
3. [3] Thierfelder L, Watkins H, MacRae C et al. α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77:701-712.
4. [4] Johnson MC, Payne RM, Grant JW, Strauss AW. The genetic basis of paediatric heart disease. Ann Med 1995;27;289-300.
5. [5] Canter CE, Strauss AW. Cardiomyopathies-when to think of congenital causes. Contemp Pediatr 1995;12:25-33.
6. [6] Hale DE, Bennett MJ. Fatty acid oxidation disorders: a new class of metabolic diseases. J Pediatr 1992;121:1-11.
7. [7] Roe CR, Coates PM. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS and Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, New York; McGraw-Hill, 1995:1501-1533.
8. [8] Wallace DC. Mitochondrial DNA variation in human evolution, degenerative disease, and aging. Am J Hum Genet 1995;57:201-223.
9. [9] Wallace D. Diseases of the mitochondrial DNA. Annu Rev Biochem 1992;61:1175-1212.
10. [10] Aprille JR. Mitochondrial cytopathies and mitochondrial DNA mutations. Curr Sci 1991:1045-1054.
11. [11] Johns DR. Mitochondrial DNA and disease. New Engl J Med 1995;333;638-644.
12. [12] Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 1994;79:427-436.
13. [13] Taroni F. Carnitine palmitoyltransferase deficiency. In: Gilman S, Goldstein GW and Waxman SG, eds. La Jolla; Arbor Publishing, 1995.
14. [14] Stanley CA, Hale DE, Berry GT, Deleeuw S, Boxer J, Bonnefont JP. A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. N Engl J Med 1992;327:19-23.
15. [15] Tein I, DiMauro S, DeVivo DC. Recurrent childhood myoglobinuria. Adv Pediatr 1990;37:77-117.
16. [16] Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 1989;83:927-936.
17. [17] Holt IJ, Harding AE, Morgan-Hughes JA. Deletions in muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-719.
18. [18] Shoffner JM, Lott MT, Lezza AMS, Seibel P, Ballinger SW, Wallace DC. MERRF is associated with a mitochondrial DNA tRNA-lys mutation. Cell 1990;61:931-937.
19. [19] Goto Y, Nonaka I, Horai S. A mutation in tRNA-leu gene associated with MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-653.
20. [20] Goto Y, Horai S, Matsuoka T, Koga Y, Nihei K, Kobayashi M, Nonaka I. MELAS: A correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992;42:545-550.
21. [21] Suzuki Y, Harada K, Miura Y, Sato W, Hayasaka K, Kawamura K, Takada G. MELAS decrease in diastolic left ventricular function assessed by echocardiography. Pediatr Cardiol 1993;14:162-166.
22. [22] Schon EA, Tritschler H-J, Moraes C, Arnaudo E, DiMauro S, Miranda A, Bonilla E. Mitochondrial myopathies. Int Pediatr 1992;7:23-27.
23. [23] Lewis W, Papoian T, Gonzalez B, Louis H, Kelly DP, Payne RM, Grody WW. Mitochondria ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab Invest 1991;65:228-236.
24. [24] DeVivo DC, Tein I. Primary and secondary disorders of carnitine metabolism. Int Pediatr 1990;5:134-141.
25. [25] Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts. N Engl J Med 1988;319:1331-1336.
26. [26] Tripp ME, Katcher ML, Peters HA, Gilbert EF, Arya S, Hodach RJ, Shugh AL. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: A treatable cardiomyopathy. N Engl J Med 1981;305;385-390.
27. [27] Stanley CA. Carnitine disorders. Adv Pediatr 1995;42:209-242.
28. [28] Bennett MJ, Hale DE, Pollitt RJ, Stanley CA, Variend S. Endocardial Fibroelastosis and primary carnitine deficiency due to a defect in the plasma membrane carnitine transporter. Clin Cardiol 1996;19:243-246.
29. [29] Britton CH, Schultz RA, Zhang Z, Esser V, Foster DW, McGarry JD. Human liver mitochondrial CPT-I. Proc Natl Acad Sci USA 1995;92:1984-1988.
30. [30] Taroni F, Verderio E, Fiorucci S, Cavadini P, Finocchiaro G, Uziel G, Lamatea E, Gellera C, DiDonato S. Molecular characterization of CPT-II deficiency. Proc Natl Acad Sci USA 1992;89:8429-8433.
31. [31] Taroni F, Verderio E, Dworzak F, Willems PJ, Cavadini P, DiDonato S. Identification of a common mutation in CPT-II gene in familial recurrent myoglobinuria patients. Nature Genet 1993;4:314-319.
32. [32] Verderio E, Cavadini P, Montermini L, Wang H, Lamatea E, Finocchiaro G, DiDonato S, Gellera C, Taroni F. CPT-II deficiency. Hum Mol Genet 1995;4:19-29.
33. [33] Hug G, Bove KE, Soukup S. Lethal neonatal multiorgan deficiency of CPT-II. N Engl J Med 1991;325:1862-1865.
34. [34] Demaugre F, Bonnefont J-P, Colonna M, Cepanec C, Leroux J-P, Saudubray J-M. Infantile CPT-II deficiency with hepatomuscular symptoms and sudden death. J Clin Invest 1991;87:859-864.
35. [35] DiMauro S, Melis-DiMauro P. Muscle CPT deficiency and myoglobinuria. Science 1973;182:929031.
36. [36] Uchida Y, Izai K, Orii T, Hashimoto T. Novel fatty acid β-oxidation enzymes in rat liver mitochondria. J Biol Chem 1992;267:1034041.
37. [37] Strauss AW, Powell CK, Hale DE, Anderson MM, Ahuja A, Brackett JC, Sims HF. Molecular basis of human mitochondrial VLCAD deficiency causing cardiomyopathy and sudden death in childhood. Proc Natl Acad Sci USA 1995;92:10496-10500.
38. [38] Souri M, Aoyama T, Orii K, Yamaguchi S, Hashimoto T. Mutation analysis of VLCAD deficiency. Am J Hum Genet 1996:58:97-106.
39. [39] Andresen BS, Bross P, Vianey-Saban C, et al. Cloning and characterization of human VLCAD, chromosomal assignment of the gene and identification of four patients of nine different mutations within the VLCAD gene. Hum Mol Genet 1996; in press.
40. [40] Fukao T, Yamaguchi S, Orii T, Schutgens RBH, Osumi T, Hashimoto T. Identification of three mutant alleles of the gene for mitochondrial acetoacetyl-CoA thiolase. J Clin Invest 1992;89:474-479.
41. [41] Henry CG, Strauss AW, Keating JP, Hillman RE. Congestive cardiomyopathy associated with β-ketothiolase deficiency. J Pediatr 1981;99:754-757.
42. [42] Wanders RJA, Duran M, Ijlst L, deJager JP. Sudden infant death and LCHAD. Lancet 1989;2:52-53.
43. [43] Brackett JC, Sims HF, Rinaldo P, Shapiro S, Powell CK, Bennett MJ, Strauss AW. Two a subunit donor splice site mutations cause human trifunctional protein deficiency. J Clin Invest 1995;95:2076-2082.
44. [44] Sims HF, Brackett JC, Powell CK, Treem WR, Hale DE, Bennett MJ, Gibson B, Shapiro S, Strauss AW. The molecular basis of pediatri LCHAD deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA 1995;92:841-845.
45. [45] Ijlst L, Wanders RJA, Ushikubo S, Kamijo T, Hashimoto T. Molecular basis of LCHAD deficiency: identification of the major disease-causing mutation in the α-subunit of the mitochondrial trifunctional protein. Biochim Biophys Acta 1994;1215:347-350.
46. [46] Hale DE, Batshaw ML, Coates PM, Freeman FE, Goodman SI, Singh I, Stanley CA. Long chain acyl-CoA dehydrogenase deficiency: An inherited cause of nonketotic hypoglycemia. Pediatr Res 1985;19:666-671.
47. [47] Kelly DP, Mendelsohn NJ, Sobel BE, Bergmann SR. Detection and assessment by positron emission tomography of a genetically-determined defect in myocardial fatty acid utilization. Am J Cardiol 1993;71:738-744.
48. [48] Rinaldo P, O'Shea JJ, Coates PM, Hale DE, Stanley CA, Tanaka K. Medium chain acyl-CoA dehydrogenase deficiency: Diagnosis by stable-isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylproprionyl glycine. N Engl J Med 1988;319:1308-1313.
49. [49] Pitkanen S, Merante F, McLeod DR, Applegarth D, Tong T, Robinson BH. Familial cardiomyopathy with cataracts and lactic acidosis. Pediatr Res 1996;39:513-521.
50. [50] Shoffner JM, Wallace DC. Oxidative phosphorylation disorders. In: Scriver CR, Beaudet AL, Sly WS and Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, New York; McGraw Hill, 1995:1535-1609.